Oral fertility medications such as clomiphene citrate or letrozole are commonly used as the first line of treatment. If the ovarian response is insufficient, injectable gonadotropins may be prescribed. The main risk to manage is ovarian hyperstimulation syndrome (OHSS), which occurs when the ovaries over-respond to stimulation. At Galwa Care Hospital, this risk is carefully minimized through individualized dosing, real-time follicular monitoring, and timely protocol adjustments throughout the cycle.

Ovulation Induction is typically completed within a single menstrual cycle of approximately 2 to 3 weeks from the start of medication to the pregnancy test. It is one of the most time-efficient first-line fertility treatments available. It is frequently combined with IUI to improve conception chances by ensuring insemination occurs at precisely the peak of ovulation, and it also forms the ovarian stimulation phase of a full IVF treatment cycle.

Yes, there is a slightly increased risk of multiple pregnancy with Ovulation Induction, particularly if more than one follicle develops and releases an egg. At Galwa Care Hospital, monitoring protocols are specifically designed to minimize this risk through careful medication dosage titration and close follicle assessment throughout each cycle. If too many follicles develop, the cycle may be adjusted or converted to avoid the risk of higher-order multiple pregnancy.

When follicle monitoring confirms that the follicles have reached their optimal maturity, typically 18 to 20mm in diameter, a trigger injection is administered to induce the final maturation and precise timed release of the egg. Intercourse or IUI is then timed accordingly within the following 36 to 40 hours. A blood-based pregnancy test is conducted 10 to 14 days after confirmed ovulation for the most accurate and reliable result.